Editors Picks
India’s Ozempic Moment
Semaglutide, sold under the blockbuster brands Ozempic and Wegovy, has become one of the most talked-about drugs in recent memory.
Continue Reading
Subscribe to unlock full access to this article.
ABOUT AUTHORS
BISMAN KAUR
Bisman Kaur is associated with Remfry & Sagar since 2002, Bisman is a trademark attorney with extensive experience in advising clients on the adoption and protection of brand names. Her strong knowledge of the nuances of assignment and licensing of rights makes her well versed with issues related to brand strategy development and expansion. She also leads media outreach, communications and publishing activities at the Firm. As Editor of the Firm’s newsletter – Letter From India – Bisman ensures clients and associates are kept updated on the latest IP news from India as well as happenings at the Firm’s office. The Firm participates in various events and conferences through the year, including organising its own ‘Remfry’s IP Seminar’ and the BRICS IP Forum, for which she is the point of contact.
PANKAJ SONI
Pankaj has over two decades of experience and serves as the Patent Chair at the Firm. He is widely recognised for his expertise in patent litigation strategy and is well versed with the nuances of SEP litigation in India. He has provided extensive advisory support in the SEP/FRAND space, and is particularly adept at crafting winning approaches to claim construction, infringement, and invalidity analysis. Pankaj has secured multiple successes before various High Courts in India for Fortune 500 clients and has also been involved in patent litigation before U.S. Federal Courts. His technical focus spans electronics and telecommunications, computer related inventions, mechanical.